# OnCo record cargo-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cargo-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cargo-therapeutics" ;
  schema:name "CARGO Therapeutics"@en ;
  schema:description "CARGO developed a CAR T-cell therapy aimed at a protein called CD22 for patients with large B-cell lymphoma whose cancer had come back after CD19 CAR T treatment. It went public in 2023 and was bought by Concentra Biosciences in 2025 after winding down development."@en ;
  schema:url <https://onco.cc/companies/cargo-therapeutics/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.sec.gov/edgar/browse/?CIK=0001966494>, <https://www.sec.gov/Archives/edgar/data/1966494/000119312525156413/d74755dex991.htm>, <https://www.sec.gov/Archives/edgar/data/1966494/000119312525183141/d58314d8k.htm>, <https://www.sec.gov/Archives/edgar/data/1966494/000119312523294468/d25647dex991.htm>, <https://www.sec.gov/edgar/browse/?CIK=0001966494> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> .